Anne VanLent
Director/Board Member at TREVI THERAPEUTICS, INC.
Net worth: 89 641 $ as of 2024-03-30
Profile
Anne M.
VanLent founded Technology Compass Group LLC in 2001, where she worked as Principal from 2001 to 2010 and AMV Advisors in 2008, where she is working as President from 2008.
Ms. VanLent also currently works at International AIDS Vaccine Initiative, Inc., as Vice Chairman from 2008, Trevi Therapeutics, Inc., as Independent Director from 2018, McCarter Theatre Co., as Trustee, and Princeton Area Community Foundation, as Trustee.
Ms. VanLent also formerly worked at i-STAT Corp., as Director, Integra LifeSciences Holdings Corp., as Independent Director from 1997 to 2013, Penwest Pharmaceuticals Co., as Director from 1998 to 2010, Traws Pharma, Inc., as Independent Director from 2014 to 2016, Aegerion Pharmaceuticals, Inc., as Independent Director from 2015 to 2016, OCERA Therapeutics LLC, as Independent Director from 2011 to 2017, Beacon Therapeutics (USA), Inc., as Independent Director from 2016 to 2022, The American Red Cross of Central New Jersey, as Director, Aviragen Therapeutics, Inc., as Lead Independent Non-Executive Director, ObsEva SA, as Director from 2021 to 2023, Novelion Therapeutics, Inc., as Director from 2013 to 2017, Vaxart, Inc., as Independent Director from 2013 to 2020, The Liposome Co., Inc., as Chief Financial Officer & Senior Vice President from 1985 to 1993, Barrier Therapeutics, Inc., as Chief Financial Officer & Executive Vice President from 2002 to 2008, Sarnoff Corp., as Executive Vice President-Portfolio Management from 1997 to 2001, and Neurogenics, Inc., as Chief Financial Officer.
Ms. VanLent received her undergraduate degree from Mount Holyoke College.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
TREVI THERAPEUTICS, INC.
0.04% | 2023-06-27 | 25,983 ( 0.04% ) | 89 641 $ | 2024-03-30 |
Anne VanLent active positions
| Companies | Position | Start |
|---|---|---|
| TREVI THERAPEUTICS, INC. | Director/Board Member | 2018-10-09 |
| McCarter Theatre Co. | Director/Board Member | - |
International AIDS Vaccine Initiative, Inc.
 International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | Director/Board Member | 2010-11-29 |
| AMV Advisors | Founder | 2008-04-30 |
Princeton Area Community Foundation
 Princeton Area Community Foundation Miscellaneous Commercial ServicesCommercial Services Princeton Area Community Foundation is a charity organization that supports the health and well-being of communities. The non-profit company is based in Lawrenceville, NJ. Jeffrey Vega has been the CEO of the company since 2015. | Director/Board Member | - |
Former positions of Anne VanLent
| Companies | Position | End |
|---|---|---|
| OBSEVA SA | Director/Board Member | 2023-06-28 |
| APPLIED GENETIC TECHNOLOGIES CORPORATION | Director/Board Member | 2022-11-30 |
| VAXART, INC. | Director/Board Member | 2020-05-31 |
| OCERA THERAPEUTICS INC | Director/Board Member | 2017-12-10 |
| ░░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Training of Anne VanLent
| Mount Holyoke College | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 5 |
|---|---|
| INTEGRA LIFESCIENCES HOLDINGS CORPORATION | Health Technology |
| TRAWS PHARMA, INC. | Health Technology |
| TREVI THERAPEUTICS, INC. | Health Technology |
| OBSEVA SA | Health Technology |
| VAXART, INC. | Health Technology |
| Private companies | 17 |
|---|---|
i-STAT Corp.
 i-STAT Corp. Medical SpecialtiesHealth Technology i-STAT Corp. is used to develope, manufacture and market medical diagnostic products for blood analysis that provide healthcare professionals critical diagnostic information accurately and immediately at the point of patient care. Founded in 1983 by Imants Lauks, i-STAT was headquartered in East Windsor, NJ. | Health Technology |
The Liposome Co., Inc.
 The Liposome Co., Inc. Pharmaceuticals: MajorHealth Technology The Liposome Co., Inc. is a biopharmaceutical company engaged in the discovery, development, manufacturing and marketing of proprietary lipid- and liposome-based pharmaceuticals, primarily for the treatment of cancer and other related life-threatening illnesses. | Health Technology |
Penwest Pharmaceuticals Co.
 Penwest Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology Penwest Pharmaceuticals Co. is a speciality pharmaceutical company focused on the development and commercialisation of therapies for the treatment of neurological disorders. Its oral controlled release technologies are also available for the development and commercialisation of products in multiple therapeutic areas. The company was founded in 1991 and is headquartered in Patterson, NY. | Health Technology |
Barrier Therapeutics, Inc.
 Barrier Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Barrier Therapeutics, Inc. discovers, develops, and commercializes pharmaceutical products in the field of dermatology in the United States. It markets Xolegel, Vusion, and Solage gels. The firm markets its products to dermatologists and other target physicians through sales force. The company was founded in 2001 and is headquartered in Princeton, NJ | Health Technology |
Aegerion Pharmaceuticals, Inc.
 Aegerion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aegerion Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in the development and commercialization of therapies for patients with debilitating rare diseases. The company was founded by David I. Scheer, Gerald L. Wisler and William H. Lewis in 2005 and is headquartered in Cambridge, MA. | Health Technology |
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | Health Technology |
Sarnoff Corp.
 Sarnoff Corp. Miscellaneous Commercial ServicesCommercial Services Sarnoff Corp. provides contract research services in the fields of electronics, biomedicine and information technology. Its areas of research include optoelectronics, genomics, digital video, lasers and wireless communications. The company was founded in 1942 and is headquartered in Princeton, NJ. | Commercial Services |
Ocera Therapeutics, Inc.
 Ocera Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ocera Therapeutics, Inc. manufactures pharmaceuticals products. The company was founded in 2004 and is headquartered in Hazelwood, MO. | Health Technology |
Beacon Therapeutics (USA), Inc.
 Beacon Therapeutics (USA), Inc. Pharmaceuticals: GenericHealth Technology Applied Genetic Technologies Corp. is a clinical stage biotechnology company, which engages in the usage of a gene therapy platform to develop transformational genetic therapies for patients suffering from rare and debilitating diseases. The firm also focuses on conducting clinical trials in the field of ophthalmology, optogenetics, adrenoleukodystrophy, and otology. The company was founded by Richard Jude Samulski, Nicholas Muzyczka, William W. Hauswirth, Terence R. Flotte, and Barry J. Byrne on January 19, 1999 and is headquartered in Alachua, FL. | Health Technology |
The American Red Cross of Central New Jersey
 The American Red Cross of Central New Jersey Services to the Health IndustryHealth Services American Red Cross of Central New Jersey is a non-profit organisation. It focuses on disaster relief, supporting America’s military families, lifesaving blood, health and safety services and international in New Jersey region. The company is headquartered in Princeton, NJ. | Health Services |
| Technology Compass Group LLC | |
| McCarter Theatre Co. | |
| AMV Advisors | |
Aviragen Therapeutics, Inc.
 Aviragen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aviragen Therapeutics, Inc. engages in the discovery and development of direct-acting antivirals to treat infections. Its product candidates include vapendavir, an oral treatment for human rhinovirus infections in moderate-to-severe asthmatics; BTA074, a topical antiviral treatment for genital warts caused by human papillomavirus types 6 & 11; BTA585, an oral fusion protein inhibitor for the treatment of RSV-A and RSV-B infections; and laninamivir octanoate, a one-time, inhaled treatment for influenza A and B infections. The company was founded on November 8, 2012 and is headquartered in Alpharetta, GA. | Health Technology |
Princeton Area Community Foundation
Princeton Area Community Foundation Miscellaneous Commercial ServicesCommercial Services Princeton Area Community Foundation is a charity organization that supports the health and well-being of communities. The non-profit company is based in Lawrenceville, NJ. Jeffrey Vega has been the CEO of the company since 2015. | Commercial Services |
Novelion Therapeutics, Inc.
 Novelion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Novelion Therapeutics, Inc. engaged in the development and commercialization of pharmaceuitical products. It focused in providing new standards of care for individuals living with rare diseases. The company was founded on February 3, 1981 and was headquartered in Vancouver, Canada. | Health Technology |
| Neurogenics, Inc. |
- Stock Market
- Insiders
- Anne VanLent
